methylene blue has been researched along with Osteosarcoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Atay, AA; Demir, ÜF; Malbora, B; Sarbay, H; Yılmaz, G | 1 |
| Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C | 1 |
| Guan, J; Lai, X; Leung, AW; Wang, X; Xu, C; Zhang, H | 1 |
| Bertolone, SJ; Jaffe, N; Raj, AB | 1 |
| Aeschlimann, C; Cerny, T; Küpfer, A; Wermuth, B | 1 |
| Alexandre, C; Bourrin, S; Genty, C; Palle, S; Vanelle, L | 1 |
| Stewart, SL | 1 |
| Kido, R; Kuroiwa, T; Takikawa, O; Yamazaki, F | 1 |
8 other study(ies) available for methylene blue and Osteosarcoma
| Article | Year |
|---|---|
Ifosfamide induced encephalopathy in a child with osteosarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Osteosarcoma | 2021 |
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Child; Cytochrome P-450 CYP2B6; Female; Genetic Predisposition to Disease; Humans; Ifosfamide; Male; Methylene Blue; Neuroprotective Agents; Osteosarcoma; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Treatment Outcome | 2018 |
Photodynamic action of methylene blue in osteosarcoma cells in vitro.
Topics: Apoptosis; Cell Line, Tumor; Humans; Methylene Blue; Microscopy, Confocal; Osteosarcoma; Photochemotherapy; Photosensitizing Agents | 2014 |
Methylene blue reversal of ifosfamide-related encephalopathy.
Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Electroencephalography; Enzyme Inhibitors; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methylene Blue; Neurotoxicity Syndromes; Osteosarcoma; Tomography, X-Ray Computed | 2004 |
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female; Glutarates; Humans; Ifosfamide; Injections, Intravenous; Lung Neoplasms; Methylene Blue; Osteosarcoma; Premedication; Sarcosine | 1994 |
Colorimetric evaluation of cultured osteoblast-like cells (ROS 17/2.8).
Topics: Animals; Cell Count; Colorimetry; DNA, Neoplasm; Evaluation Studies as Topic; Methylene Blue; Microscopy, Electron, Scanning; Models, Biological; Neoplasm Proteins; Optics and Photonics; Osteoblasts; Osteosarcoma; Spectrophotometry; Thymidine; Tritium; Tumor Cells, Cultured | 1994 |
Postchemotherapy confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Humans; Ifosfamide; Mesna; Methylene Blue; Neurotoxicity Syndromes; Oncology Nursing; Osteosarcoma | 2001 |
Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.
Topics: Ascorbic Acid; Carcinoma, Squamous Cell; Enzyme Induction; Humans; Immunosorbent Techniques; Interferon-gamma; Lung; Methylene Blue; Osteosarcoma; Oxygenases; Recombinant Proteins; Tryptophan; Tryptophan Oxygenase; Tumor Cells, Cultured | 1988 |